CDC-RFA-DP18-1808.pdf

PDF 3 MB Posted Apr 20, 2018

Attached to: Networking2Save: CDCs National Network Approach to Preventing and Controlling Tobacco-related Cancers in Special Populations
Opportunity number: CDC-RFA-DP18-1808
Issued by: Department of Health and Human Services Centers for Disease Control and Prevention

About this file

From the source

Revised Full Anouncement

View the file

Other files

File	Type	Posted
oppCDC-RFA-DP18-1808-cfda93.431-cidCDC-RFA-DP18-1808-instructions.pdf	PDF	Apr 16, 2018

On GovTribe

Work with this file

Download the original file
Contacts named in this file
Similar government files
Ask GovTribe AI about this file

Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

Centers for Disease Control

National Center for Chronic Disease Prevention and Health Promotion

Networking2Save: CDCs National Network Approach to Preventing and Controlling Tobacco-related Cancers in Special Populations

CDC-RFA-DP18-1808

Application Due Date: 06/18/2018

Networking2Save: CDCs National Network Approach to Preventing and Controlling Tobacco-related Cancers in Special Populations

CDC-RFA-DP18-1808

TABLE OF CONTENTS

Part I. Overview Information A. Federal Agency Name B. Funding Opportunity Title C. Announcement Type D. Agency Funding Opportunity Number E. Catalog of Federal Domestic Assistance (CFDA) Number F. Dates G. Executive Summary

Part II. Full Text A. Funding Opportunity Description B. Award Information C. Eligibility Information D. Application and Submission Information E. Review and Selection Process F. Award Administration Information G. Agency Contacts H. Other Information I. Glossary

Part I. Overview Information Applicants must go to the synopsis page of this announcement at www.grants.gov and click on the "Send Me Change Notifications Emails" link to ensure they receive notifications of any changes to CDC-RFA-DP18-1808. Applicants also must provide an e-mail address to www.grants.gov to receive notifications of changes.

A. Federal Agency Name:

Centers for Disease Control and Prevention (CDC) / Agency for Toxic Substances and Disease Registry (ATSDR) B. Notice of Funding Opportunity (NOFO) Title:

Networking2Save: CDCs National Network Approach to Preventing and Controlling Tobacco-related Cancers in Special Populations C. Announcement Type: New - Type 1 This announcement is only for non-research activities supported by CDC. If research is proposed, the application will not be considered. For this purpose, research is defined at https ://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf.

Guidance on how CDC interprets the definition of research in the context of public health can be found at https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html (See section 45 CFR 46.102(d)).

New-Type 1

D. Agency Notice of Funding Opportunity Number:

CDC-RFA-DP18-1808

E. Catalog of Federal Domestic Assistance (CFDA) Number:

93.431 F. Dates:

1. Due Date for Letter of Intent (LOI): 05/04/2018

2. Due Date for Applications: 06/18/2018, 11:59 p.m. U.S. Eastern

Standard Time, at www.grants.gov.

The recipient must indicate the population to be addressed. Only one award will be made per target population.

3. Date for Informational Conference Call:

CDC will conduct a conference call for all interested applicants to provide technical assistance and respond to any questions regarding this Notice of Funding Opportunity. This call will take place on 05/07/2018 at 03:00 p.m. US Eastern Standard Time. The dial in information is 1- 866-556-2078, Participant passcode: 3335689#. The call will also be recorded. Instructions for accessing the recording and a list of frequently asked questions will be available at https://www .cdc.gov/tobacco/about/foa/national-networks-nofo/index.htm.

G. Executive Summary:

1. Summary Paragraph:

The Office of Smoking and Health (OSH) and the Division of Cancer Prevention and Control (DCPC) seek to fund a consortium of population-specific, public health-oriented, National Networks to impact the prevalence of commercial tobacco use and tobacco related cancers.

https://www.grants.gov https://www.grants.gov https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html https://www.grants.gov https://www.cdc.gov/tobacco/about/foa/national-networks-nofo/index.htm https://www.cdc.gov/tobacco/about/foa/national-networks-nofo/index.htm

Strategies and activities will focus on network administration and management; training and technical assistance; engagement of the priority populations in national, state, tribal, territorial interventions; and mass reach health communications. Applicants will identify and focus on one of the following target populations: 1). African Americans; 2). American Indians/Alaskan Natives; 3). Asian Americans/Pacific Islanders/Hawaiian Natives; 4). Latinos/Hispanics; 5).

Lesbian, Gay, Bisexual and Transgender persons; 6). Persons with Low Socioeconomic Status;

7). Persons with Mental Health and Substance Abuse Disorders; and 8). Geographically Defined Populations with High Commercial Tobacco Use and Related Health Disparities. Expected program outcomes include, but not limited to: Increased delivery of evidence-based interventions to reach and impact priority populations; Increased comprehensive smokefree and comprehensive multiunit housing policies; Increased retail strategies; Increased quit attempts among priority populations; Increased physical activity among priority populations; and Increased cancer screening as recommended by the U.S. Preventive Services Taskforce among priority populations.

a. Eligible Applicants: Open Competition

b. NOFO Type: Cooperative Agreement

c. Approximate Number of Awards: 8

d. Total Period of Performance Funding: $17,500,000 For 5 years, subject to availability of funding including both direct and indirect cost.

e. Average One Year Award Amount: $425,000

f. Total Period of Performance Length: 5

g. Estimated Award Date: 09/01/2018

h. Cost Sharing and / or Matching Requirements: N Cost sharing of 10% is strongly encouraged for this program. In addition, leveraging other resources and related ongoing efforts to promote sustainability is strongly encouraged.

Examples include complementary funding from other non-federal sources. Applicants should coordinate with multiple sectors, such as public health, environmental protection, transportation, education, health care delivery, agriculture and others.

Part II. Full Text A. Funding Opportunity Description

Part II. Full Text

1. Background

a. Overview The Office on Smoking and Health and Division of Cancer Prevention and Control seeks to build on the successes of previously funded National Networks (CDC-RFA-DP13-1314) and expand work to address tobacco- and cancer-related health disparities among these populations.

Applicants will identify and focus on one of the following target populations: African Americans;

American Indians/Alaskan Natives; Asian Americans/Pacific Islanders/Hawaiian Natives;

Hispanics; Lesbian, Gay, Bisexual and Transgender persons; persons with low socioeconomic status; persons with mental health and substance abuse disorders; and geographically-defined populations with high commercial tobacco use and related health disparities. They will addresses the unique need for population-specific capacity and infrastructure to support tobacco and cancer control strategies. They will promote access to tobacco cessation services, cancer prevention, and treatment and survivor resources for populations experiencing disparities.

Tobacco Burden: Cigarette smoking and exposure to secondhand smoke are the leading preventable cause of death in the United States, resulting in about 480,000 premature deaths and 16 million smoking-related illnesses each year. Annual costs linked to tobacco-related illnesses are nearly $280 billion in medical expenses and lost productivity. Electronic cigarette (e-cigarette) use among US youth and young adults has greatly increased, growing 900% among high school students from 2011 to 2015.

Tobacco-Related Cancers: Cancer is the second leading cause of death in the United States, with about 1.5 million new diagnoses and over 550,000 deaths each year. Commercial tobacco use is the leading preventable cause of cancer and cancer deaths. Twelve cancers are caused by commercial tobacco use and evidence exists for a causal relationship with several others (https ://www.cdc.gov/vitalsigns/cancerandtobacco/index.html.) Tobacco use also impacts health outcomes in patients and survivors with these tobacco-related cancers as well as other cancers.

Each year, 660,000 people are diagnosed with, and 343,000 people die from, a cancer related to commercial tobacco use. The direct cost of cancer care was $125 billion in 2010, and is expected to increase to $158 billion in 2020.

Tobacco- and Cancer-Related Health Disparities: Tobacco-related disparities exist among racial/ethnic and other groups, including persons with low socioeconomic status, persons with histories of mental illnesses and substance abuse disorders, the lesbian, gay, bisexual, and transgender community, persons with disabilities, persons living in certain geographic regions, and among youth high school drop-outs. About 25% of US adults have some form of mental illness or substance use disorder, and consume almost 40% of all cigarettes smoked by adults.

Differences in flavored tobacco use, including menthol, exist across states and subpopulations.

Subpopulations with the greatest overall prevalence of flavored tobacco use include persons who are male, younger in age, non-Hispanic, or non-white.

Disparities in the number of smokers who quit persist among specific groups including non- Hispanic blacks, persons with lower education, persons with disabilities, persons on Medicaid or without health insurance, and those with limited English proficiency.

Secondhand tobacco smoke exposure causes heart disease and lung cancer in nonsmoking adults and other acute conditions in children and adults. Forty percent of the U.S. population lives in state or local communities with no comprehensive smoke-free air laws.

b. Statutory Authorities 42 U.S.C. 241(a) and 42 U.S.C. 247b(k)(2)

c. Healthy People 2020 Tobacco Use focus areas: TU-1; TU-2;TU-3 TU-4; TU-6; TU-7; TU-8; TU-9; TU-10; TU-11;

https://www.cdc.gov/vitalsigns/cancerandtobacco/index.html https://www.cdc.gov/vitalsigns/cancerandtobacco/index.html

TU-12; TU-13; TU-14; TU-; TU-16; TU-17; TU-18; TU-19; TU-20.

https://www.healthypeople.gov/2020/topics-objectives/topic/tobacco-use/objectives Cancer focus areas: C-14; C-15; C-16; C-17; C-18; C-20 https://www.healthypeople.gov/2020/topics-objectives/topic/cancer/objectives Immunization and Infectious Disease focus areas: IID-11.4; IID-11.5 https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-disea ses Disability and Health focus areas: DH-2: DH-4 https://www.healthypeople.gov/2020/topics-objectives/topic/disability-and-health/objectives

d. Other National Public Health Priorities and Strategies National Prevention Strategy:

https://www.surgeongeneral.gov/priorities/prevention/strategy/index.html#The Priorities CDC FY 2018 Congressional Justification Performance Measures:

https://www.cdc.gov/budget/documents/fy2018/fy-2018-cdc-congressional-justification.pdf

Cancer Prevention and Control Measure (page 232-234): 4.9.1; 4.9.2; 4.Q; 4.R

? Tobacco Measures (page 225-226): 4.6.2a; 4.6.3; 4.6.4 ; Reduce death and disability due to tobacco use by 5% in the implementation area.

e. Relevant Work Accelerating the decline in commercial tobacco use and reducing the burden of tobacco- and cancer- related health disparities are CDC strategic priorities. Reducing commercial tobacco use is one of CDC?s Winnable Battles, www.cdc.gov/WinnableBattles/Tobacco/index.html.

This NOFO aligns with the CDC NCCCP and NTCP goals to: 1) Promote the primary and secondary prevention of cancer; 2) Address the public health needs of cancer survivors; 3) Prevent initiation of tobacco use among youth and young adults; 4) Eliminate exposure to secondhand smoke; 5) Promote cessation of tobacco use among adults and youth; and 6) Identify and eliminate tobacco-related and cancer health disparities.

This NOFO builds on the successes of CDC-RFA-DP13-1304: Consortium of National Networks to Impact Populations Experiencing Tobacco-related and Cancer Health Disparities. https ://www.cdc.gov/tobacco/about/coop-agreements/national-networks/index.htm

2. CDC Project Description

a. Approach

Bold indicates period of performance outcome.

CDC-RFA-DP18-1808 Logic Model: Networking2Save: CDC?s National Network Approach to Preventing and Controlling Tobacco-related Cancers in Special https://www.healthypeople.gov/2020/topics-objectives/topic/tobacco-use/objectives https://www.healthypeople.gov/2020/topics-objectives/topic/cancer/objectives https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases https://www.healthypeople.gov/2020/topics-objectives/topic/disability-and-health/objectives https://www.surgeongeneral.gov/priorities/prevention/strategy/index.html%23The%20Priorities https://www.cdc.gov/budget/documents/fy2018/fy-2018-cdc-congressional-justification.pdf https://www.cdc.gov/tobacco/about/coop-agreements/national-networks/index.htm https://www.cdc.gov/tobacco/about/coop-agreements/national-networks/index.htm

Populations Bold indicates period of performance outcome

Strategies and Activities

Short-term Outcomes Intermediate Outcomes Long-Term Outcomes

Network Administering and Management

- Convene network members and facilitate communication among members

- Recruit and maintain membership

- Develop and maintain information collection system on membership

- Disseminate population-specific data

Training

- Assess knowledge, skills and abilities of network members and CDC-funded programs for training

- Using an assessment to plan, develop, Increased awareness of evidence-based strategies among populations and organizations serving populations experiencing tobacco- and cancer-related disparities

Increased communication, coordination, cooperation and collaboration among network members, CDC-funded programs about target populations Increased knowledge of training needs of network participants and their partners

Increased knowledge of tobacco and cancer control strategies by network participants and their partners

Increased capacity of CDC-funded tobacco and cancer control programs in improving the collection and use of the target population data

Enhanced capacity of state, local, tribal, territorial and jurisdictional programs to implement tailored interventions

Strengthened relationships between organizations serving target populations, CDC-funded programs, and other funded networks.

Increased mobilization of key stakeholders to prioritize strategic cancer prevention and control planning

Increased implementation of tobacco and cancer prevention and control strategies by network participants and their partners

Increased delivery of evidence-based interventions to reach and impact target populations

Enhanced population-specific data collection systems, analyses and interpretation at the national, state, local, tribal, territorial and jurisdictional levels

Increases in

Enhanced systems impacting the identification and elimination of tobacco and cancer related health disparities

Coordination among network participants and partners

Integration and use of population specific strategies by CDC-funded tobacco and cancer control programs

Increased tobacco cessation among the target population

Decreased exposure to SHS among the target population

Decreased initiation of commercial tobacco use among the target population

Increased detection of cancer at early stage and deliver appropriate training

- Monitor and report outcomes of training activities

Technical Assistance (TA)

- Assess the capacity of CDC funded state programs to implement interventions within the target population

- Use findings from a needs assessment to plan and deliver appropriate TA

- Monitor and report on TA activities and outcomes

- Advise CDC-funded programs on available population-specific data and its use

Involving Target populations in National and State, Tribal, Territorial Interventions to

Increased support for comprehensive smokefree workplace and multiunit housing strategies

Increased support for cessation coverage and awareness of benefits

Increased organizational policies and health system practices that support quality cancer screening for the target population

Increased knowledge, attitudes, and intentions for cancer screening

Increased support for community programs linked to clinical services that help cancer survivors from the target population manage cancer diagnoses, comorbidities, and improve quality of life

Increased awareness of the dangers of commercial tobacco use, secondhand smoke, the health benefits of quitting, and resources to help tobacco users quit Increased awareness of the benefits of vaccination, screening and early detection of cancer.

comprehensive smokefree strategies

Increases in comprehensive smokefree multiunit housing strategies

Increases in retail strategies

Increased quit attempts among target populations

Increased physical activity among target populations

Increased intentions among the target population to receive appropriate cancer screening and vaccinations

Increased cancer screening among target populations

Increased cancer-related vaccinations among target populations

Increased intentions among the target population to quit commercial tobacco use among target populations

Decreased incidence of advanced stage disease among the target populations

Decreased disparities in cancer health outcomes

Bolded outcomes have associated performance measures.

Prevention and Control Tobacco- Related Cancers Environmental and system level change

- Health care systems strategies

- Community-clinical linkages

Mass Reach Health Communication s

- Expand and leverage CDC media campaigns and science/evidenc e based publications though network channels

- Support media engagement efforts

i. Purpose Fund a consortium of National Networks to reduce tobacco and cancer related health disparities including: African Americans; American Indians/Alaskan Natives; Asian Americans/Pacific Islanders/Hawaiian Natives; Latinos/Hispanics; LGBT persons; Persons with Low Socioeconomic Status; Persons with Mental Health and Substance Abuse Disorders;

Geographically Defined Populations with High Commercial Tobacco Use. Program strategies include network management; training/technical assistance; population focused interventions; and mass reach health communications.

ii. Outcomes

Short-term outcome

Increased capacity of CDC-funded tobacco and cancer control programs in improving the collection and use of the target population data.

Intermediate outcomes

Strengthened relationships between organizations serving target populations, CDC-funded programs/partners, and other funded National Networks

Increased delivery of evidence-based interventions to reach and impact target populations Increases in comprehensive smokefree strategies Increases in comprehensive smokefree multiunit housing strategies Increases in retail strategies Increased quit attempts among target populations Increased physical activity among target populations Increased cancer screening among target populations

Long-term outcome

Decreased incidence of advanced stage disease among the target populations

iii. Strategies and Activities Recipients must implement at least one activity from each of the overall strategies below. Some activities are required; an asterisk notes activities that are required to be described in the work plan each year.

Administer and manage a National Network

Convene network members and facilitate communication among members to determine appropriate strategies to reduce the high prevalence of commercial tobacco use and tobacco-related cancers.

Recruit and maintain organizations to become active members of the network.* Develop and maintain information collection system on network members and their contributions to the network?s activities and efforts.* Disseminate population-specific data to key decision makers and stakeholders.

Providing training and technical assistance to network members and CDC-funded programs Training

Assess knowledge, skills and abilities of network members and CDC-funded NTCP and the NCCCP for training.

Use an assessment to plan, develop, and deliver appropriate training.

Monitor and report outcomes of training activities.*

Technical Assistance

Assess the capacity of CDC funded state programs to implement interventions within the target population.

Use findings from a needs assessment to plan and deliver appropriate technical assistance to the CDC funded NTCP and the NCCCP.

Monitor and report on technical assistance activities and outcomes.* Advise CDC-funded programs on available population-specific data and its use.

Increase reach of national, state, tribal, territorial, and local interventions Recipients should work with CDC funded NTCP and the NCCCP to ensure culturally appropriate inclusion of target populations in intervention work, and by engaging network members in community-based interventions around three major chronic disease domains. As appropriate, recipients should collaborate with the other CDC-funded National Networks in enhancing the impact of evidence-based interventions with the target populations.

Environmental and system level change to address tobacco and cancer prevention and control. Such interventions include, but are not limited to, smokefree multiunit housing, comprehensive smokefree strategies, retail strategies, urban design and land use policies, food product placement policies, and increased access to community wellness programs.

Health care systems interventions include, but are not limited to, provider and health system efforts to support tobacco-related cessation and cancer prevention, including increasing access to quality screening and treatment services and clinical trials, or increasing efforts to reduce vaccine-preventable cancers.

Community-clinical linkages include, but are not limited to, patient navigation to facilitate timely access to screening, education-related recommendation from The Community Guide to promote health equity, or enhancing methods to identify and describe health disparities.

Increase reach of mass reach health communications

Expand and leverage CDC media campaigns (including Tips from Former SmokersR campaign) and science/evidence based publications though network channels.*

Support media engagement efforts at the national and state levels through tailoring messages to target populations.

1. Collaborations

a. With other CDC programs and CDC-funded organizations:

Recipients will be required to collaborate with other CDC programs and CDC funded organizations as described below. The applicant must provide evidence of their capacity to collaborate in the following ways:

Describe capacity to participate in stakeholder meetings and other collaborative efforts with public health partners to provide expert consultation to CDC and CDC-funded programs (as requested).

Participate with CDC-funded programs and CDC in collaborative efforts to proactively identify needs and response to request from NCCCP (https://www.cdc.gov/cancer/ncccp /index.htm) and NTCP (https://www.cdc.gov/tobacco/stateandcommunity/tobacco_co ntrol_programs/ntcp/index.htm) and their partners (within the limits of the funded program strategies and related activities).

Proactively identify needs and provide technical assistance and training to the NCCCP (https://www.cdc.gov/cancer/ncccp/index.htm) and NTCP (https://www.cdc.gov/tobacco /stateandcommunity/tobacco_control_programs/ntcp/index.htm) and their partners (within the limits of the funded program strategies and related activities).

Meet regularly and highly encouraged to seek collaborative opportunities with other network recipients funded under this cooperative agreement in enhancing the work with the target population.

Seek collaborative opportunities with CDC funded state Disability and Health Programs especially where these states overlap with efforts by NTCP and NCCC programs. (https ://www.cdc.gov/ncbddd/disabilityandhealth/programs.html )

Seek collaborative opportunities with CDC funded Immunization program.

Applicants are required to provide letters of support as evidence of collaboration in working with CDC programs/CDC-funded organizations. These letters should state the organization's commitment to joining the proposed network and a description of the organizations experience working with CDC programs/CDC-funded organizations. The letters of support must be dated within 30 days of the application from CDC programs and CDC-funded organizations with whom they will collaborate. Applicants must file the letters of support, as appropriate, name the file ?Letters of Support?, and upload it as a PDF file at www.grants.gov.

b. With organizations not funded by CDC:

The recipient is required to establish and maintain a National Network that is comprised of multi-sector participants representing national, regional, state, tribal, territorial, jurisdictional and local level commercial tobacco use prevention, comprehensive cancer control, chronic disease prevention, behavioral health programs, and other public health programs/partners/organizations with specific expertise and experience improving and enhancing public health systems (as described below). The applicant must provide evidence of their capacity to collaborate in the following ways:

As part of its network, required to build and/or continue strategic public health partnerships and collaborations with:

o Federal agencies such as Indian Health Service, Federal Drug Administration, Department of Defense, Housing and Urban Development, National Cancer Institute, Substance Abuse and Mental Health Services Administration as well as local health departments that have a role in achieving the NOFO outcomes and proposed activities.

o Key national organizations such as American Cancer Society, American Heart Association, American Lung Association, Tobacco Free Kids, American Nonsmokers? Rights Foundation, Legal Consortium, National Association of Chronic Disease Directors, The Association of State and Territorial Health https://www.cdc.gov/cancer/ncccp/index.htm https://www.cdc.gov/cancer/ncccp/index.htm https://www.cdc.gov/tobacco/stateandcommunity/tobacco_control_programs/ntcp/index.htm https://www.cdc.gov/tobacco/stateandcommunity/tobacco_control_programs/ntcp/index.htm https://www.cdc.gov/cancer/ncccp/index.htm https://www.cdc.gov/tobacco/stateandcommunity/tobacco_control_programs/ntcp/index.htm https://www.cdc.gov/tobacco/stateandcommunity/tobacco_control_programs/ntcp/index.htm https://www.cdc.gov/ncbddd/disabilityandhealth/programs.html https://www.cdc.gov/ncbddd/disabilityandhealth/programs.html http://www.grants.gov/

Officials, National Colorectal Cancer Round Table, National Association of Community Health Centers, National Cancer Registrars Association that have a role in achieving the NOFO outcomes and proposed activities.

The applicant is required to provide letters of support as evidence of collaboration in working with federal agencies, local health departments, and key national organizations. These letters should state the organization's commitment to joining the proposed network and a description of the organization's experience working with federal agencies, local health departments, and key national organizations. The letters of support must be dated within 30 days of the application from the federal agencies, local health departments, and key national organizations with whom they will collaborate. Applicants must file the letters of support, as appropriate, name the file ?Letters of Support?, and upload it as a PDF file at www.grants.gov.

2. Target Populations National Networks must identify and focus on populations experiencing high prevalence of commercial tobacco use and tobacco related cancers including: 1) African Americans; 2) American Indians/Alaskan Natives; 3) Asian Americans/Pacific Islanders/Hawaiian Natives; 4) Latinos/Hispanics; 5) Lesbian, Gay, Bisexual and Transgender persons; 6) Persons with Low Socioeconomic Status; 7) Persons with Mental Health and Substance Abuse Disorders; and 8) Geographically Defined Populations with High Commercial Tobacco Use and Related Health Disparities.

Applicants addressing racial and ethnic populations should address the inclusion of subpopulations within the identified target population that can benefit from the program strategies listed in this NOFO. These subpopulations can include groups such as people with low socioeconomic status, people with mental health or substance abuse disorders, non-English speaking populations, Lesbian, Gay, Bisexual, and Transgender (LGBT) populations, persons with disabilities, or other populations who may otherwise be missed by the program. In addition, applicants will be expected to provide specific activities to address the variances in disparities within the identified target populations. (For more information, see CDC Health Disparities and Inequalities Report, 2011, www.cdc.gov/Features/HealthDisparitiesReport/).

a. Health Disparities CDC recognizes that modifiable risks, such as commercial tobacco use, influence cancer outcomes and are closely related to social and economic opportunities, health behaviors, and the physical environment in which people live. The organizations awarded under this NOFO will convene networks of partners committed to improving tobacco-related and cancer prevention health outcomes in disparate populations.

iv. Funding Strategy Up to 8 programs will be awarded. No more than one award for each target population will be selected for funding. Only one application should be submitted per organization. Organizations will not be funded for more than one target population.

b. Evaluation and Performance Measurement http://www.cdc.gov/Features/HealthDisparitiesReport/

i. CDC Evaluation and Performance Measurement Strategy

CDC will use performance measures and annual progress reports, as well as independent evaluation activities to answer key CDC evaluation questions, such as:

1. To what extent do networks maintain active membership that is representative of the populations they target (geographically, ethnically, etc.), and how are they maintaining or growing the network?s representation over time?

2. How does the structure of a recipient (e.g., whether they are affiliate-based or independent) influence interaction and success with state programs?

3. How can CDC best facilitate connection and collaboration with CDC-funded programs, including between the funded networks?

4. What is the impact of network activity on state capacity to collect data on target populations?

5. What is the impact of network technical assistance on state, tribal, territorial ability reach target populations with evidence-based interventions?

6. How do networks best achieve synergy to address intersectional disparity issues (e.g., behavioral health in racial/ethnic populations)?

7. How can networks scale up work with CDC-funded programs to leverage resources and increase impact?

8. How did networks help reach tobacco and cancer prevention and control goals in states, territories and tribes?

As part of CDC evaluation requirements, recipients will report performance measures annually using a template provided by CDC. These measures will demonstrate the contribution of recipient strategies to reducing tobacco- and cancer-related health disparities, and will be aggregated by CDC across recipients and time. CDC will work with recipients to finalize the following proposed performance measures, including how they are operationalized and reported.

Outcomes and Associated Proposed Performance Measures, by Tier

Associated Outcomes

Tier 1 All recipients must report each of #1-3.

Increased capacity of CDC-funded tobacco and cancer control programs in improving the collection and use of the target population data.

1. Number of state, tribal, and/or territorial tobacco and cancer control programs who improve the collection and use of the following types of population-specific data to tailor and/or target interventions for the target population:

a. Commercial Tobacco use in adults (e.g., BRFSS, adult tobacco surveys)

b. Commercial Tobacco use in youth (e.g., YRBS, youth tobacco surveys)

c. Quitline intake (i.e., state quitline assessing all demographic indicators)

d. Cancer surveillance data (i.e., USCS, BRFSS, EHR data)

Strengthened relationships between organizations serving target populations, CDC-funded programs, other funded networks, and CDC

2. At least two examples of the outcomes of network members and/or partners? relationships with CDC-funded programs resulting from network participation (e.g., trainings, tools, webinars, mentoring), including an assessment of the impact of each improvement

Increased delivery of evidence-based interventions to reach and impact target populations

3. At least two examples how evidence-based interventions that reach and impacted target populations through state, tribal, territorial or local programs were improved after consultation with the network from:

a. Tobacco control programs

b. Cancer control programs

Tier 2 Recipients must report annually, based on selected strategies, for each state receiving technical assistance on these strategies:

· At least two measures from #4-7

· #8 if strategy is selected

· Both #9-10

Increases in comprehensive smokefree strategies

4. Increase in number of persons covered by 100% comprehensive smokefree laws (covering restaurants, workplaces, and bars) in states where no statewide law exists1

Increases in comprehensive smokefree multiunit housing strategies

5. Increase in number of multi-unit housing complexes that implement comprehensive smokefree policies, and the number of units/persons protected by these policies

Increases in retail strategies 6. Increase in retail strategies implemented, and population reach of these strategies.

Increased quit attempts among target populations

7. Increase in adults among the target population who have attempted to quit tobacco using the state quitline

Increased physical activity among target populations

8. Increase in adults in the target population who report moderate physical activity >=5 times per week or who report vigorous physical activity >=3 times per week

Increased cancer screening 9. Increase in cancer screening in target population (Recipient will propose activities to increase screening for either breast among target populations2 cancer, cervical cancer, or colorectal cancer screening based on population-specific burden.)

a. Breast: Increase in women age 50-74 in target population who have had a mammogram in the past 2 years

b. Cervical: Increase in women age 21-65 in the target population who have been screened for cervical cancer within the past 3 years.

c. Colorectal: Increase in adults age 50-75 in the target population who have been screened for colorectal cancer.

Decreased incidence of advanced stage disease among the target populations

10. Decrease in incidence of advanced stage disease in target population (Recipient will propose activities to decrease incidence of advanced stage disease for either breast cancer, cervical cancer, or colorectal cancer screening based on population-specific burden.)

a. Breast: Decreased incidence of advanced stage disease among women in the target population.

b. Cervical: Decreased incidence of advanced stage disease among women in the target population.

c. Colorectal: Decreased incidence of advanced stage disease among adults in the target population

1 Activities to support this performance measure include education, technical assistance and training, and resource sharing but must not include impermissible lobbying (For more information regarding anti-lobbying restrictions for CDC Grantees, visit: http://www.cdc.gov /grants/documents/Anti-Lobbying_Restrictions_for_CDC_Grantees_July_2012.pdf ).

2Based on U.S. Preventive Services Task Force cancer screening recommendations.

ii. Applicant Evaluation and Performance Measurement Plan Applicants must provide an evaluation and performance measurement plan that demonstrates how the recipient will fulfill the requirements described in the CDC Evaluation and Performance Measurement and Project Description sections of this NOFO. At a minimum, the plan must describe:

How applicant will collect the performance measures, respond to the evaluation questions, and use evaluation findings for continuous program quality improvement.

How key program partners will participate in the evaluation and performance measurement planning processes.

Available data sources, feasibility of collecting appropriate evaluation and performance data, and other relevant data information (e.g., performance measures proposed by the http://www.cdc.gov/grants/documents/Anti-Lobbying_Restrictions_for_CDC_Grantees_July_2012.pdf applicant) Plans for updating the Data Management Plan (DMP), if applicable, for accuracy throughout the lifecycle of the project. The DMP should provide a description of the data that will be produced using these NOFO funds; access to data; data standards ensuring released data have documentation describing methods of collection, what the data represent, and data limitations; and archival and long-term data preservation plans. For more information about CDC’s policy on the DMP, see https://www.cdc.gov/grants/additionalrequirements/ar-25.html.

Where the applicant chooses to, or is expected to, take on specific evaluation studies, they should be directed to:

Describe the type of evaluations (i.e., process, outcome, or both).

Describe key evaluation questions to be addressed by these evaluations.

Describe other information (e.g., measures, data sources).

Recipients will be required to submit a more detailed Evaluation and Performance Measurement plan, including a DMP, within the first 6 months of award, as described in the Reporting Section of this NOFO.

Applicants must provide an evaluation and performance measurement plan that will fulfill the requirements in the CDC Evaluation and Performance Measure section. Applicants must:

Develop an initial evaluation and performance plan to indicate how they will identify progress in implementing program strategies, activities, and achieving program outcomes.

Ensure that the evaluation plan follows the CDC Evaluation Framework and describes how they will collect data to report on the performance measures.

This plan should cover the 5-year cooperative agreement, and can be updated as work plans change throughout the cooperative agreement. It should include process and outcome evaluation questions, and should include a data collection plan that informs performance measures.

Evaluation plans should be developed in alignment with the CDC Framework for Evaluation in Public Health. Recipients will be required to update CDC on progress in implementing the plan by reporting evaluation findings; evaluation findings must be reported annually in the Annual Progress Report, and per CDC guidance throughout the cooperative agreement.

More information on developing evaluation plans can be found at https://www.cdc.gov/obesity /downloads/cdc-evaluation-workbook-508.pdf.

c. Organizational Capacity of Recipients to Implement the Approach Organizational capacity ensures applicants demonstrate their ability to successfully execute the NOFO strategies and meet the program outcomes. Applicants must demonstrate and provide evidence of:

1. Organizational capacity, expertise and experience to enhance the quality and performance of public health programs, public health data and information systems, public health https://www.cdc.gov/grants/additionalrequirements/ar-25.html https://www.cdc.gov/obesity/downloads/cdc-evaluation-workbook-508.pdf https://www.cdc.gov/obesity/downloads/cdc-evaluation-workbook-508.pdf practice and services, public health partnerships, and public health resources that focus on the prevalence of commercial tobacco use and tobacco related cancers in specific populations.

2. Experience serving the identified target population to impact the prevalence of commercial tobacco use and tobacco related cancers through systems based approaches.

3. Capacity to engage diverse, multi-sector public health partners across all 50 states, tribes, territories, and jurisdictions.

4. Capacity and structures in place to administer a National Network comprised of stakeholders representing national, regional, state, tribal, territory, jurisdictional and/or local level commercial tobacco control, comprehensive cancer control, chronic disease prevention within the identified target population.

5. Successful experience convening diverse, multi-sector partners to promote the use of evidence-based (including policy-based interventions and systems change approaches) approaches and culturally competent strategies for addressing the prevalence of commercial tobacco use and tobacco related cancers in the identified target population.

6. Demonstrated knowledge and understanding of appropriate methods to reach and engage organizations which serve members of the identified target populations.

7. An existing, active, multi-sector membership that includes partners with demonstrated success implementing culturally appropriate evidence-based (including policy-based interventions and systems change approaches) strategies.

8. Adequate physical space and electronic information and communication systems to implement the program.

9. Adequate program management and staffing plans with sufficient workforce capacity and competence to ensure program success. Management and staffing plans should, at a minimum, include

10. 1.0 FTE program manager and 0.5 FTE program evaluator. The curriculum vitae?s/resumes should indicate evidence of the staff capacity. The Applicant must name this file "CVs/Resumes" and upload it at www.grants.gov.

11. Adequate performance measurement, evaluation, quality improvement, travel, fiscal management, and financial management procedures and full capacity to manage contracting and procurements efforts, including the ability to write and award subcontracts in accordance with 45 C.F.R. 75, as applicable.

12. Experience in conducting and using needs assessments to work with CDC-funded programs, including the use of assessment findings to improve programmatic activities and ultimately show impact.

13. Ability to attend CDC sponsored trainings, meetings and events and other training opportunities.

14. Ability to conduct sustainability planning that assures the implementation of National Network activities are scalable and are proven to be effective beyond the CDC funding cycle.

d. Work Plan CDC will use performance measures and annual progress reports, as well as independent evaluation activities to answer key CDC evaluation questions, such as: